SIRTURO 100 mg, tablet 24 tablets
Active ingredients: Bedaquiline, Bedaquiline fumarate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIRTURO 100 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) thermoformée(s) aluminium de 6 comprimé(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Feb 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65690588CIP73001581CIP133400930015810Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE BÉDAQUILINEcomprimé | 120,89 mg · un comprimé | SA |
| BÉDAQUILINEcomprimé | 100 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.